158
Views
0
CrossRef citations to date
0
Altmetric
LETTER

Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]

ORCID Icon, ORCID Icon &
Pages 3889-3890 | Received 28 Nov 2022, Accepted 01 Dec 2022, Published online: 14 Dec 2022

References

  • Nikolic DM, Ranin LT, Stojanovic MM, Ilic ID, Gostiljac DM, Soldatovic IA. Homeostatic microbiome disruption as a cause of insulin secretion disorders. Candida albicans, a new factor in pathogenesis of diabetes A STROBE compliant cross-sectional study. Med. 2022;101(45):e31291. doi:10.1097/MD.0000000000031291
  • Ahmad A, Yang W, Chen G, et al. Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals. PLoS One. 2019;14(12):1–15. doi:10.1371/journal.pone.0226372
  • Ye J, Wu Z, Zhao Y, Zhang S, Liu W, Su Y. Role of gut microbiota in the pathogenesis and treatment of diabetes mullites: advanced research-based review. Front Microbiol. 2022;13:1–13. doi:10.3389/fmicb.2022.1029890
  • Wang J, Li W, Wang C, et al. Enterotype bacteroides is associated with a high risk in patients with diabetes: a pilot study. J Diabetes Res. 2020;2020:1–11. doi:10.1155/2020/6047145